LXCHEM.BO(LXCHEM.BO)
LXCHEM.BO
No analyst ratings available
No analyst price targets available for LXCHEM.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $67.13B | $75.58B |
| Low | $60.80B | $63.41B |
| High | $73.46B | $87.76B |
| EBITDA Avg | $6.40B | $7.20B |
| Low | $5.79B | $6.04B |
| High | $7.00B | $8.36B |
| EBIT Avg | $4.41B | $4.97B |
| Low | $4.00B | $4.17B |
| High | $4.83B | $5.77B |
| Net Income Avg | $3.72B | $4.38B |
| Low | $3.26B | $3.75B |
| High | $4.17B | $5.02B |
| EPS Avg | $13.40 | $15.80 |
| Low | $11.76 | $13.51 |
| High | $15.04 | $18.09 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $7.92B | $7.84B | $7.92B |
| Low | $7.92B | $7.84B | $7.92B |
| High | $7.92B | $7.84B | $7.92B |
| EBITDA Avg | $755M | $747M | $754M |
| Low | $755M | $747M | $754M |
| High | $755M | $747M | $754M |
| EBIT Avg | $521M | $515M | $520M |
| Low | $521M | $515M | $520M |
| High | $521M | $515M | $520M |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |